203 related articles for article (PubMed ID: 29850793)
21. Redox imbalance due to the loss of mitochondrial NAD(P)-transhydrogenase markedly aggravates high fat diet-induced fatty liver disease in mice.
Navarro CDC; Figueira TR; Francisco A; Dal'Bó GA; Ronchi JA; Rovani JC; Escanhoela CAF; Oliveira HCF; Castilho RF; Vercesi AE
Free Radic Biol Med; 2017 Dec; 113():190-202. PubMed ID: 28964917
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA NNT-AS1 functions as an oncogene in breast cancer via repressing ZFP36 expression.
Pan QH; Fan YH; Wang YZ; Li DM; Hu CE; Li RX
J Biol Regul Homeost Agents; 2020; 34(3):795-805. PubMed ID: 32691576
[TBL] [Abstract][Full Text] [Related]
23. Undesirable effects of chemical inhibitors of NAD(P)
Bicego R; Francisco A; Ruas JS; Siqueira-Santos ES; Castilho RF
Arch Biochem Biophys; 2020 Oct; 692():108535. PubMed ID: 32781052
[TBL] [Abstract][Full Text] [Related]
24. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
25. A spontaneous mutation in the nicotinamide nucleotide transhydrogenase gene of C57BL/6J mice results in mitochondrial redox abnormalities.
Ronchi JA; Figueira TR; Ravagnani FG; Oliveira HC; Vercesi AE; Castilho RF
Free Radic Biol Med; 2013 Oct; 63():446-56. PubMed ID: 23747984
[TBL] [Abstract][Full Text] [Related]
26. Three-Dimensional Model of Human Nicotinamide Nucleotide Transhydrogenase (NNT) and Sequence-Structure Analysis of its Disease-Causing Variations.
Metherell LA; Guerra-Assunção JA; Sternberg MJ; David A
Hum Mutat; 2016 Oct; 37(10):1074-84. PubMed ID: 27459240
[TBL] [Abstract][Full Text] [Related]
27. The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
Özata DM; Caramuta S; Velázquez-Fernández D; Akçakaya P; Xie H; Höög A; Zedenius J; Bäckdahl M; Larsson C; Lui WO
Endocr Relat Cancer; 2011 Oct; 18(6):643-55. PubMed ID: 21859927
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.
Gu Y; Zhu Z; Pei H; Xu D; Jiang Y; Zhang L; Xiao L
Aging (Albany NY); 2020 Feb; 12(3):2333-2346. PubMed ID: 32019904
[TBL] [Abstract][Full Text] [Related]
30. Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells.
Sbiera S; Leich E; Liebisch G; Sbiera I; Schirbel A; Wiemer L; Matysik S; Eckhardt C; Gardill F; Gehl A; Kendl S; Weigand I; Bala M; Ronchi CL; Deutschbein T; Schmitz G; Rosenwald A; Allolio B; Fassnacht M; Kroiss M
Endocrinology; 2015 Nov; 156(11):3895-908. PubMed ID: 26305886
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Follow-Up of Three Family Members with a Novel
Krasovec T; Sikonja J; Zerjav Tansek M; Debeljak M; Ilovar S; Trebusak Podkrajsek K; Bertok S; Tesovnik T; Kovac J; Suput Omladic J; Hartmann MF; Wudy SA; Avbelj Stefanija M; Battelino T; Kotnik P; Groselj U
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627102
[TBL] [Abstract][Full Text] [Related]
32. Aging-dependent mitochondrial bioenergetic impairment in the skeletal muscle of NNT-deficient mice.
Navarro CDC; Francisco A; Costa EFD; Dalla Costa AP; Sartori MR; Bizerra PFV; Salgado AR; Figueira TR; Vercesi AE; Castilho RF
Exp Gerontol; 2024 Aug; 193():112465. PubMed ID: 38795789
[TBL] [Abstract][Full Text] [Related]
33. microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
Kwok GTY; Zhao JT; Glover AR; Gill AJ; Clifton-Bligh R; Robinson BG; Ip JCY; Sidhu SB
Oncologist; 2019 Jun; 24(6):e241-e250. PubMed ID: 30918109
[TBL] [Abstract][Full Text] [Related]
34. Combined mineralocorticoid and glucocorticoid deficiency is caused by a novel founder nicotinamide nucleotide transhydrogenase mutation that alters mitochondrial morphology and increases oxidative stress.
Weinberg-Shukron A; Abu-Libdeh A; Zhadeh F; Carmel L; Kogot-Levin A; Kamal L; Kanaan M; Zeligson S; Renbaum P; Levy-Lahad E; Zangen D
J Med Genet; 2015 Sep; 52(9):636-41. PubMed ID: 26070314
[TBL] [Abstract][Full Text] [Related]
35. Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer.
Laha D; Grant RRC; Mishra P; Boufraqech M; Shen M; Zhang YQ; Hall MD; Quezado M; De Melo MS; Del Rivero J; Zeiger M; Nilubol N
J Exp Clin Cancer Res; 2022 Sep; 41(1):282. PubMed ID: 36151566
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of nicotinamide nucleotide transhydrogenase and its naturally occurring antisense RNA in gastric cancer.
Esfandi F; Taheri M; Kahaei MS; Omrani MD; Kholghi Oskooei V; Ghafouri-Fard S
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e191-e196. PubMed ID: 31309731
[TBL] [Abstract][Full Text] [Related]
37. Nicotinamide nucleotide transhydrogenase expression analysis in multiple sclerosis patients.
Eftekharian MM; Taheri M; Arsang-Jang S; Komaki A; Ghafouri-Fard S
Int J Neurosci; 2019 Dec; 129(12):1256-1260. PubMed ID: 31474168
[No Abstract] [Full Text] [Related]
38. Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma.
Korah R; Healy JM; Kunstman JW; Fonseca AL; Ameri AH; Prasad ML; Carling T
Mol Cancer; 2013 Aug; 12():87. PubMed ID: 23915220
[TBL] [Abstract][Full Text] [Related]
39. Pyruvate dehydrogenase complex and nicotinamide nucleotide transhydrogenase constitute an energy-consuming redox circuit.
Fisher-Wellman KH; Lin CT; Ryan TE; Reese LR; Gilliam LA; Cathey BL; Lark DS; Smith CD; Muoio DM; Neufer PD
Biochem J; 2015 Apr; 467(2):271-80. PubMed ID: 25643703
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA NNT-AS1 promotes gastric cancer proliferation and invasion by regulating microRNA-363 expression.
Wang X; Ren M; Li Y; Hu J; Lu G; Ma W; Guo D; Lu X; He S
J Cell Biochem; 2019 Apr; 120(4):5704-5712. PubMed ID: 30324628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
